BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mora Pinzon MC, Buie R, Liou J, Shirley DK, Evans CT, Ramanathan S, Poggensee L, Safdar N. Outcomes of Community and Healthcare-onset Clostridium difficile Infections. Clinical Infectious Diseases 2019;68:1343-50. [DOI: 10.1093/cid/ciy715] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Al-Tawfiq JA, Rabaan AA, Bazzi AM, Raza S, Noureen M. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia. Am J Infect Control 2020;48:1152-7. [PMID: 32122671 DOI: 10.1016/j.ajic.2020.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Zacharioudakis IM, Zervou FN, Phillips MS, Aguero-Rosenfeld ME. Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hospitals. Diagn Microbiol Infect Dis 2021;100:115346. [PMID: 33647544 DOI: 10.1016/j.diagmicrobio.2021.115346] [Reference Citation Analysis]
3 Russo EM, Kuntz J, Yu H, Smith J, Hauser RG, Halchenko Y, Young-xu Y. Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration. Infect Control Hosp Epidemiol 2019;40:997-1005. [DOI: 10.1017/ice.2019.160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Babady NE, Aslam A, McMillen T, Syed M, Zehir A, Kamboj M. Genotypic correlation between post discharge Clostridiodes difficle infection (CDI) and previous unit-based contacts. J Hosp Infect 2021;109:96-100. [PMID: 33171187 DOI: 10.1016/j.jhin.2020.10.028] [Reference Citation Analysis]
5 Rajasingham R, Enns EA, Khoruts A, Vaughn BP. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines. Clin Infect Dis 2020;70:754-62. [PMID: 31001619 DOI: 10.1093/cid/ciz318] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
6 Lawrence J, Kitchin N, Anderson AS, Pride MW, Jansen KU, Gruber WC, Peng Y, Yi K, Knirsch C, Webber C. Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years. Vaccine 2021;39:5991-6003. [PMID: 34483022 DOI: 10.1016/j.vaccine.2021.05.028] [Reference Citation Analysis]
7 Akiyama S, Yamada A, Komaki Y, Komaki F, Micic D, Sakuraba A. Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2021;55:43-51. [PMID: 32053529 DOI: 10.1097/MCG.0000000000001330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 D'Agata EMC, Apata IW, Booth S, Boyce JM, Deaver K, Gualandi N, Neu A, Nguyen D, Novosad S, Palevsky PM, Rodgers D; Nephrologist Transforming Dialysis Safety Committee. Electronic address: ntds@asn-online.org. Suggestions for the prevention of Clostridioides difficile spread within outpatient hemodialysis facilities. Kidney Int 2021;99:1045-53. [PMID: 33667504 DOI: 10.1016/j.kint.2021.02.028] [Reference Citation Analysis]
9 Shaffer SR, Witt J, Targownik LE, Kao D, Lee C, Smieliauskas F, Rubin DT, Singh H, Bernstein CN. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. J Infect 2020;81:758-65. [PMID: 32980389 DOI: 10.1016/j.jinf.2020.09.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gupta S, Zhu J, McCarty TR, Pruce J, Kassam Z, Kelly C, Fischer M, Allegretti JR. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. J Gastroenterol Hepatol 2021. [PMID: 33682170 DOI: 10.1111/jgh.15483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]